AlphaStocks
3.7
Weak

TG THERAPEUTICS, INC. (TGTX)

Health Care / Biotechnology

S&P SmallCap 600

$33.59

Scores poorly across most models. Proceed with caution.

Weak

Score based on 4 of 5 models — moderate confidence

#908out of 1127 in Health Care

Is TG THERAPEUTICS, INC. a Good Investment in 2026?

TG THERAPEUTICS, INC. (TGTX) scores 3.7 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Lynch model rates TG THERAPEUTICS, INC. as Attractive. However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 66%). TG THERAPEUTICS, INC. currently trades above its estimated fair value of $30, suggesting limited upside at current prices. TG THERAPEUTICS, INC. ranks #908 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E12.1ROE24.6Market Cap5B

Estimated Fair Value

$30.2711% above

Trading slightly above estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

4/9

Buffett

Neutral

Business quality & competitive moat

Graham

Neutral

19% above fair value

Lynch

Attractive

Growth rate vs price (PEG)

Greenblatt

Caution

Bottom half (rank 66%)

Frequently Asked Questions

Is TG THERAPEUTICS, INC. (TGTX) a good investment?
Based on AlphaStocks' composite analysis, TG THERAPEUTICS, INC. (TGTX) scores 3.7 out of 10, earning a Weak rating. This score is below average, suggesting caution. Trading slightly above estimated fair value.
What is TG THERAPEUTICS, INC.'s Piotroski F-Score?
TG THERAPEUTICS, INC.'s Piotroski F-Score status is Neutral. The raw score is 4/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is TGTX overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $30, TGTX appears overvalued. The stock currently trades 11% above its estimated fair value. Trading slightly above estimated fair value.
How does TGTX compare to other Health Care stocks?
TG THERAPEUTICS, INC. ranks #908 out of 1127 stocks in the Health Care sector, placing it in the top 81% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about TGTX?
AlphaStocks evaluates TGTX using five proven investment models. Piotroski: Neutral; Buffett: Neutral; Graham: Neutral; Lynch: Attractive; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 3.7/10.

Similar Stocks

PARRFTIAZN

Compare TGTX with

TGTX vs PARRTGTX vs FTITGTX vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer